全文获取类型
收费全文 | 6771篇 |
免费 | 332篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 108篇 |
妇产科学 | 99篇 |
基础医学 | 888篇 |
口腔科学 | 536篇 |
临床医学 | 475篇 |
内科学 | 1689篇 |
皮肤病学 | 102篇 |
神经病学 | 883篇 |
特种医学 | 173篇 |
外科学 | 927篇 |
综合类 | 28篇 |
一般理论 | 4篇 |
预防医学 | 318篇 |
眼科学 | 157篇 |
药学 | 371篇 |
中国医学 | 28篇 |
肿瘤学 | 292篇 |
出版年
2024年 | 5篇 |
2023年 | 79篇 |
2022年 | 176篇 |
2021年 | 293篇 |
2020年 | 183篇 |
2019年 | 236篇 |
2018年 | 272篇 |
2017年 | 151篇 |
2016年 | 191篇 |
2015年 | 247篇 |
2014年 | 307篇 |
2013年 | 347篇 |
2012年 | 536篇 |
2011年 | 616篇 |
2010年 | 304篇 |
2009年 | 267篇 |
2008年 | 477篇 |
2007年 | 431篇 |
2006年 | 407篇 |
2005年 | 358篇 |
2004年 | 324篇 |
2003年 | 275篇 |
2002年 | 246篇 |
2001年 | 47篇 |
2000年 | 37篇 |
1999年 | 30篇 |
1998年 | 46篇 |
1997年 | 25篇 |
1996年 | 32篇 |
1995年 | 22篇 |
1994年 | 18篇 |
1993年 | 19篇 |
1992年 | 17篇 |
1991年 | 11篇 |
1990年 | 15篇 |
1989年 | 8篇 |
1988年 | 5篇 |
1987年 | 7篇 |
1986年 | 11篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1972年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有7155条查询结果,搜索用时 15 毫秒
61.
Samir R. Kapadia MD FACC Sachin S. Goel MD Lars Svensson MD PhD Eric Roselli MD Robert M. Savage MD Lee Wallace MD Srikanth Sola MD FACC Paul Schoenhagen MD FACC Mehdi H. Shishehbor DO MPH Ryan Christofferson MD Carmel Halley MD L. Leonardo Rodriguez MD FACC William Stewart MD FACC Vidyasagar Kalahasti MD FACC E. Murat Tuzcu MD FACC 《The Journal of thoracic and cardiovascular surgery》2009,(6):1430-1435
62.
Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. 总被引:9,自引:0,他引:9
63.
Rocha Déborah Ribeiro Nery Jaqueline Freire Furini Leonardo Negri Constantino Carlos José Leopoldo Eller Lizziane Kretli Winkelströter Nai Gisele Alborghetti Nakagaki Wilson Romero 《Lasers in medical science》2020,35(8):1703-1709
Lasers in Medical Science - Studies reported the harmful effects of 2,4-D on body tissues, provoking changes in the anatomy and physiology of the kidneys, liver, and testicles. Thus, the objective... 相似文献
64.
Valgimigli M Campo G Percoco G Bolognese L Vassanelli C Colangelo S de Cesare N Rodriguez AE Ferrario M Moreno R Piva T Sheiban I Pasquetto G Prati F Nazzaro MS Parrinello G Ferrari R;Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study 《JAMA》2008,299(15):1788-1799
Context Abciximab infusion and uncoated-stent implantation is a complementary treatment strategy to reduce major adverse cardiac events in patients undergoing angioplasty for ST-segment elevation myocardial infarction (STEMI). It is uncertain whether there may be similar benefits in replacing abciximab with high-dose bolus tirofiban. Similarly, the use of drug-eluting stents in this patient population is currently discouraged because of conflicting results on efficacy reported in randomized trials and safety concerns reported by registries. Objective To evaluate the effect of high-dose bolus tirofiban and of sirolimus-eluting stents as compared with abciximab infusion and uncoated-stent implantation in patients with STEMI undergoing percutaneous coronary intervention. Design, Setting, and Patients An open-label, 2 x 2 factorial trial of 745 patients presenting with STEMI or new left bundle-branch block at 16 referral centers in Italy, Spain, and Argentina between October 2004 and April 2007. Interventions High-dose bolus tirofiban vs abciximab infusion and sirolimus-eluting stent vs uncoated stent implantation. Main Outcome Measures For drug comparison, at least 50% ST-segment elevation resolution at 90 minutes postintervention with a prespecified noninferiority margin of 9% difference (relative risk, 0.89); for stent comparison, the rate of major adverse cardiac events, defined as the composite of death from any cause, reinfarction, and clinically driven target-vessel revascularization within 8 months. Results ST-segment resolution occurred in 302 of 361 patients (83.6%) who had received abciximab infusion and 308 of 361 (85.3%) who had received tirofiban infusion (relative risk, 1.020; 97.5% confidence interval, 0.958-1.086; P < .001 for noninferiority). Ischemic and hemorrhagic outcomes were similar in the tirofiban and abciximab groups. At 8 months, major adverse cardiac events occurred in 54 patients (14.5%) with uncoated stents and 29 (7.8%) with sirolimus stents (P = .004), predominantly reflecting a reduction of revascularization rates (10.2% vs 3.2%). The incidence of stent thrombosis was similar in the 2 stent groups. Conclusions In patients with STEMI undergoing percutaneous coronary intervention, compared with abciximab, tirofiban therapy was associated with noninferior resolution of ST-segment elevation at 90 minutes following coronary intervention, whereas sirolimus-eluting stent implantation was associated with a significantly lower risk of major adverse cardiac events than uncoated stents within 8 months after intervention. Trial Registration clinicaltrials.gov Identifier: NCT00229515 相似文献
65.
66.
Santos LN Fernandes BF de Moura LR Cheema DP Maloney S Logan P Burnier MN 《Cornea》2007,26(9):1027-1031
PURPOSE: To determine the frequency and describe the histopathologic features of stromal corneal dystrophies over a 10-year period. METHODS: A single-centered, retrospective analysis was performed on corneal specimens diagnosed as stromal dystrophies retrieved from the Henry C. Witelson Ophthalmic Pathology Laboratory and Registry (Montreal, Canada) over a period of 10 years. Corneal specimens obtained during keratoplasty were subjected to hematoxylin and eosin, periodic acid-Schiff, and other special staining. RESULTS: During the period of the study, 885 corneal specimens from penetrating keratoplasties were received. Twenty-six (2.9%) specimens from a total of 22 patients showed stromal corneal dystrophies: 17 (65.4%) eyes with lattice dystrophy, 5 (19.2%) eyes with combined granular/lattice ("Avellino") dystrophy, 3 (11.5%) eyes with granular dystrophy, and 1 (3.9%) eye with macular dystrophy. CONCLUSIONS: Corneal stromal dystrophies have distinct histopathologic features, which can be diagnosed with routine and special staining, particularly for combined granular/lattice (Avellino) dystrophy. Clinically, combined granular/lattice (Avellino) dystrophy can have features of both lattice and granular dystrophies, which can be misleading for diagnosis. Lattice dystrophy was the most frequent stromal dystrophy in this particular population. 相似文献
67.
Akaishi L Tzelikis PF Gondim J Vaz R 《Journal of cataract and refractive surgery》2007,33(12):2067-2071
PURPOSE: To assess the postoperative outcomes of primary piggyback implantation using the Tecnis ZM900 multifocal intraocular lens (IOL) (Advanced Medical Optics). SETTING: Hospital Oftalmológico de Brasília, Brasília, Brazil. METHODS: Patients who had phacoemulsification with primary piggyback IOL implantation were analyzed prospectively. In all cases, a Tecnis ZM900 multifocal IOL was implanted in the capsular bag and a second silicone IOL was implanted in the ciliary sulcus. Information collected included near and distance uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and the spherical equivalent (SE) before and after the surgery. RESULTS: Twenty eyes of 12 patients were included in the study. They were followed for 6 months. The mean preoperative distance UCVA was 20/400. At the last follow-up (6 months), the mean distance UCVA was 20/29, significantly better than before referral (P<.001). The mean preoperative SE was +6.35 diopters (D) +/- 2.25 (SD). Six months after surgery, the mean SE was -0.25 +/- 0.40 D (range -1.00 to +0.50 D), significantly better than before referral (P<.001). No patient lost lines of BCVA after surgery. At the last follow-up, 90% of the eyes achieved a near UCVA of J1 and 83.3% of patients were spectacle independent for near and distance vision. A second refractive procedure was performed in 2 eyes. CONCLUSIONS: Primary piggyback implantation using the Tecnis ZM900 multifocal IOL was a simple, safe, and accurate option for patients with high hyperopia who wanted to reduce their dependency on spectacles. 相似文献
68.
PURPOSE: To assess the postoperative outcomes of piggyback implantation using the AcrySof ReSTOR intraocular lens (IOL) (model SA60D3, Alcon Surgical Laboratories). SETTING: Hospital Oftalmológico de Brasília, Brasília, Brazil. METHODS: Thirteen eyes of 7 patients who had phacoemulsification with piggyback IOL implantation were analyzed prospectively. In all cases, a ReSTOR IOL was implanted in the capsular bag and a second silicone IOL was implanted in the ciliary sulcus. Information collected included uncorrected visual acuity (UCVA) at near and distance, best corrected visual acuity (BCVA), and spherical equivalent (SE) before and after surgery. RESULTS: The patients were followed for 12 months. The mean distance UCVA was 0.25 (20/80) preoperatively and 0.88 (20/23) at the last follow-up (1 year), which was significantly better than before surgery (P<.05). The mean SE was +4.25 diopters (D) +/- 1.5 (SD) preoperatively and +0.15 +/- 0.44 D (range -0.50 to +0.75 D) at 1 year, which was significantly better than preoperatively (P<.05). No patient lost lines of BCVA after surgery. At the last follow-up, all eyes had a near UCVA of J1 and none required spectacles for near or distance vision. CONCLUSION: Piggyback implantation using the ReSTOR IOL appeared to be a safe and efficient procedure providing high-quality visual acuity for near and distance vision in selected patients. 相似文献
69.
Hanzel Jurij Almradi Ahmed Istl Alexandra C. Yang Mei Lucy Fleshner Katherine A. Parker Claire E. Guizzetti Leonardo Ma Christopher Singh Siddharth Jairath Vipul 《Digestive diseases and sciences》2022,67(2):646-660
Digestive Diseases and Sciences - Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the... 相似文献
70.
Leonardo Calegari Ramiro B. Nunes Bruna B. Mozzaquattro Douglas D. Rossato Pedro Dal Lago 《Revista brasileira de fisioterapia (S?o Carlos (S?o Paulo, Brazil))》2018,22(2):154-160